"Texas Alzheimer's Patient Experiences Life-Changing Breakthrough Treatment"

Gail Youngdale, an Alzheimer's patient in Texas, has called the recently approved treatment called lecanemab (Leqembi) life-changing. Gail participated in a global clinical trial for the drug and has been undergoing infusions, scans, and assessments for the past two years. The treatment targets the underlying cause of Alzheimer's by clearing out plaque in the brain. Gail has experienced significant improvement in her cognitive abilities and overall well-being. Medicare and Medicaid have agreed to cover the drug once it becomes available. The pace of Alzheimer's research has been remarkable, with three new drugs showing promising results in reducing cognitive decline, particularly in the early stages of the disease. Gail's story offers renewed hope for millions of people affected by Alzheimer's.